In addition, Kaplan-Meier survival analysis showed that low NR4A3 expression levels were correlated with poor prognosis of overall survival (OS) and progression-free survival (PFS) of HCC patients in the TCGA cohort (Fig. 1G-1H). The gene discussed is NR4A3; the disease is hepatocellular carcinoma.